Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

ATTENTION MGNX SHAREHOLDERS: Investors who lost money on MacroGenics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Accesswire July 25, 2024

The Schall Law Firm Is Investigating MacroGenics Inc And Urges Its Shareholders To Reach Out

Accesswire July 25, 2024

The Schall Law Firm Is Investigating MacroGenics Inc And Urges Its Shareholders To Reach Out

Accesswire July 24, 2024

MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - MGNX

Accesswire July 24, 2024

Levi & Korsinsky Reminds Shareholders of an Investigation into MacroGenics, Inc. (MGNX) Regarding Potential Securities Fraud Allegations

Accesswire July 23, 2024

The Schall Law Firm Is Investigating MacroGenics Inc And Urges Its Shareholders To Reach Out

Accesswire July 23, 2024

MGNX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by MacroGenics, Inc.

Accesswire July 22, 2024

The Schall Law Firm Is Investigating MacroGenics Inc And Urges Its Shareholders To Reach Out

Accesswire July 22, 2024

MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - MGNX

Accesswire July 22, 2024

ATTENTION MacroGenics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

Accesswire July 19, 2024

MacroGenics Incorporated Stockholders Are Encouraged By The Schall Law Firm To Reach Out Amidst Ongoing Investigation

Accesswire July 19, 2024

MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - MGNX

Accesswire July 19, 2024

Levi & Korsinsky Reminds Shareholders of an Investigation into MacroGenics, Inc. (MGNX) Regarding Potential Securities Fraud Allegations

Accesswire July 18, 2024

The Schall Law Firm Is Investigating MacroGenics Incorporated And Encourages Its Stockholders To Connect

Accesswire July 18, 2024

Shareholders that lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about Securities Fraud Investigation - MGNX

Accesswire July 17, 2024

The Schall Law Firm Is Probing MacroGenics Inc And Invites Its Shareholders To Reach Out

Accesswire July 17, 2024

An Investigation Has Commenced on Behalf of MacroGenics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MGNX Losses.

Accesswire July 16, 2024

Levi & Korsinsky Announces an Investigation on Behalf of MacroGenics, Inc. (MGNX) Shareholders Who May Have Been Affected by Fraud

Accesswire July 16, 2024

The Schall Law Firm Is Investigating MacroGenics Inc And Calls On Its Shareholders To Contact

Accesswire July 16, 2024

An Investigation Has Commenced on Behalf of MacroGenics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MGNX Losses

Accesswire July 15, 2024